BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8049565)

  • 1. Shift in clinical features, histologic findings and antigen profiles from pemphigus vulgaris to pemphigus foliaceus--two case studies.
    Kawana S; Hashimoto T; Nishikawa T; Nishiyama S
    Dermatology; 1994; 189 Suppl 1():57-9. PubMed ID: 8049565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in clinical features, histologic findings, and antigen profiles with development of pemphigus foliaceus from pemphigus vulgaris.
    Kawana S; Hashimoto T; Nishikawa T; Nishiyama S
    Arch Dermatol; 1994 Dec; 130(12):1534-8. PubMed ID: 7986127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunofluorescence and immunoblot studies on the reactivity of pemphigus vulgaris and pemphigus foliaceus sera with desmoglein 3 and desmoglein 1.
    Hashimoto T; Amagai M; Garrod DR; Nishikawa T
    Epithelial Cell Biol; 1995; 4(2):63-9. PubMed ID: 8688919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of pemphigus vulgaris and pemphigus foliaceus antigens by immunoblot analysis using different antigen sources.
    Hashimoto T; Ogawa MM; Konohana A; Nishikawa T
    J Invest Dermatol; 1990 Mar; 94(3):327-31. PubMed ID: 2307852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical transition between pemphigus foliaceus and pemphigus vulgaris correlates well with the changes in autoantibody profile assessed by an enzyme-linked immunosorbent assay.
    Komai A; Amagai M; Ishii K; Nishikawa T; Chorzelski T; Matsuo I; Hashimoto T
    Br J Dermatol; 2001 Jun; 144(6):1177-82. PubMed ID: 11422038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to the amino-terminal domain of desmoglein 1 are retained during transition from pemphigus vulgaris to pemphigus foliaceus.
    España A; Koga H; Suárez-Fernández R; Ohata C; Ishii N; Irarrazaval I; Teye K; Ohyama B; Hashimoto T
    Eur J Dermatol; 2014; 24(2):174-9. PubMed ID: 24776707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpetiform pemphigus showing reactivity with pemphigus vulgaris antigen (desmoglein 3).
    Kubo A; Amagai M; Hashimoto T; Doi T; Higashiyama M; Hashimoto K; Yoshikawa K
    Br J Dermatol; 1997 Jul; 137(1):109-13. PubMed ID: 9274636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of pemphigus vulgaris antigen extracted from normal human epidermis and comparison with pemphigus foliaceus antigen.
    Eyre RW; Stanley JR
    J Clin Invest; 1988 Mar; 81(3):807-12. PubMed ID: 3343340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of autoantigens for various bullous skin diseases by immunoblotting using different dermo-epidermal separation techniques.
    Ohata Y; Hashimoto T; Nishikawa T
    Clin Exp Dermatol; 1995 Nov; 20(6):454-8. PubMed ID: 8857335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of an adhering-junction molecule (plakoglobin) in the autoantigens of pemphigus foliaceus and pemphigus vulgaris.
    Korman NJ; Eyre RW; Klaus-Kovtun V; Stanley JR
    N Engl J Med; 1989 Sep; 321(10):631-5. PubMed ID: 2770792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in the expression of pemphigus antigens during epidermal differentiation.
    Iwatsuki K; Harada H; Yokote R; Kaneko F
    Br J Dermatol; 1995 Aug; 133(2):209-16. PubMed ID: 7547386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoblot analyses of Brazilian pemphigus foliaceus antigen using different antigen sources.
    Ogawa MM; Hashimoto T; Konohana A; Castro RM; Nishikawa T
    Arch Dermatol Res; 1990; 282(2):84-8. PubMed ID: 1693841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A soluble and immunoreactive fragment of pemphigus foliaceus antigen released by trypsinization of viable human epidermis.
    Martins CR; Labib RS; Rivitti EA; Diaz LA
    J Invest Dermatol; 1990 Aug; 95(2):208-12. PubMed ID: 2116483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinction between epidermal antigens binding pemphigus vulgaris and pemphigus foliaceus autoantibodies.
    Stanley JR; Koulu L; Thivolet C
    J Clin Invest; 1984 Aug; 74(2):313-20. PubMed ID: 6378972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of autoantigen profile between Colombian and Brazilian types of endemic pemphigus foliaceus by various biochemical and molecular biological techniques.
    Hisamatsu Y; Abreu Velez AM; Amagai M; Ogawa MM; Kanzaki T; Hashimoto T
    J Dermatol Sci; 2003 Jun; 32(1):33-41. PubMed ID: 12788527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of pemphigus antigens in drug-induced pemphigus vulgaris and pemphigus foliaceus.
    Brenner S; Bialy-Golan A; Anhalt GJ
    J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):919-23. PubMed ID: 9204055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pemphigus vulgaris associated with silicosis.
    Yamagami Y; Kohda M; Mimura S; Ueki H
    Dermatology; 1998; 197(1):55-7. PubMed ID: 9693188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.
    Mahoney MG; Wang Z; Rothenberger K; Koch PJ; Amagai M; Stanley JR
    J Clin Invest; 1999 Feb; 103(4):461-8. PubMed ID: 10021453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Locations of acantholysis in pemphigus vulgaris and pemphigus foliaceus.
    Ohata C; Ishii N; Furumura M
    J Cutan Pathol; 2014 Nov; 41(11):880-9. PubMed ID: 25265985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of anti-desmocollins I and II autoantibodies in two cases of Hallopeau type pemphigus vegetans by immunoblot analysis.
    Hashimoto K; Hashimoto T; Higashiyama M; Nishikawa T; Garrod DR; Yoshikawa K
    J Dermatol Sci; 1994 Apr; 7(2):100-6. PubMed ID: 8060912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.